TLR2 and type 1 diabetes mellitus: Non-obese diabetic (NOD) mice (a T1D model), deficient in TLR2 or treated with agonistic TLR4 monoclonal antibody, are resistant to new-onset T1D due to antigen-presenting cell tolerance and compromised adaptive T cell response [93].